Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan W Asmann

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Breast Cancer Research : BCR|October 3, 2015
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831Edith A Perez, Frederick L Baehner, Steven M Butler, et al.
Nucleic Acids Research|May 31, 2011
A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell linesYan W Asmann, Asif Hossain, Brian M Necela, et al.
European Urology Focus|July 21, 2017
Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related DeathMansi Parasramka, Daniel J Serie, Yan W Asmann, et al.
Neurology. Genetics|May 9, 2017
African American exome sequencing identifies potential risk variants at Alzheimer disease lociAurelie N'Songo, Minerva M Carrasquillo, Xue Wang, et al.
Bioinformatics (Oxford, England)|November 18, 2011
TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing dataYan W Asmann, Sumit Middha, Asif Hossain, et al.
Scientific Reports|July 1, 2017
Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Scientific Reports|May 11, 2016
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
Blood Cancer Journal|March 18, 2020
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasiasLinda B Baughn, Zhuo Li, Kathryn Pearce, et al.
Blood Cancer Journal|October 11, 2018
Loss of TNFAIP3 enhances MYD88<sub>L265P</sub>-driven signaling in non-Hodgkin lymphomaKerstin Wenzl, Michelle K Manske, Vivekananda Sarangi, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Breast Cancer Research : BCR|October 3, 2015
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831Edith A Perez, Frederick L Baehner, Steven M Butler, et al.
Nucleic Acids Research|May 31, 2011
A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell linesYan W Asmann, Asif Hossain, Brian M Necela, et al.
European Urology Focus|July 21, 2017
Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related DeathMansi Parasramka, Daniel J Serie, Yan W Asmann, et al.
Neurology. Genetics|May 9, 2017
African American exome sequencing identifies potential risk variants at Alzheimer disease lociAurelie N'Songo, Minerva M Carrasquillo, Xue Wang, et al.
Bioinformatics (Oxford, England)|November 18, 2011
TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing dataYan W Asmann, Sumit Middha, Asif Hossain, et al.
Scientific Reports|July 1, 2017
Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Scientific Reports|May 11, 2016
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
Blood Cancer Journal|March 18, 2020
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasiasLinda B Baughn, Zhuo Li, Kathryn Pearce, et al.
Blood Cancer Journal|October 11, 2018
Loss of TNFAIP3 enhances MYD88<sub>L265P</sub>-driven signaling in non-Hodgkin lymphomaKerstin Wenzl, Michelle K Manske, Vivekananda Sarangi, et al.
Pageof 17